Cargando…
Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China
This study compared the immunogenicity of inactivated SARS-CoV-2 vaccines between people living with HIV (PLWH) and HIV-negative individuals. We recruited 120 PLWH and 53 HIV-negative individuals aged 18–59 years who had received an inactivated SARS-CoV-2 vaccine in two Chinese cities between April...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875274/ https://www.ncbi.nlm.nih.gov/pubmed/35215870 http://dx.doi.org/10.3390/v14020277 |
_version_ | 1784657879144333312 |
---|---|
author | Huang, Xiaojie Yan, Ying Su, Bin Xiao, Dong Yu, Maohe Jin, Xia Duan, Junyi Zhang, Xiangjun Zheng, Shimin Fang, Yuan Zhang, Tong Tang, Weiming Wang, Lunan Wang, Zixin Xu, Junjie |
author_facet | Huang, Xiaojie Yan, Ying Su, Bin Xiao, Dong Yu, Maohe Jin, Xia Duan, Junyi Zhang, Xiangjun Zheng, Shimin Fang, Yuan Zhang, Tong Tang, Weiming Wang, Lunan Wang, Zixin Xu, Junjie |
author_sort | Huang, Xiaojie |
collection | PubMed |
description | This study compared the immunogenicity of inactivated SARS-CoV-2 vaccines between people living with HIV (PLWH) and HIV-negative individuals. We recruited 120 PLWH and 53 HIV-negative individuals aged 18–59 years who had received an inactivated SARS-CoV-2 vaccine in two Chinese cities between April and June 2021. Blood samples were tested for immunogenicity of the inactivated SARS-CoV-2 vaccines. The prevalence and severity of adverse events associated with SARS-CoV-2 vaccines were similar between PLWH and HIV-negative individuals. The seropositivity of neutralizing activity against authentic SARS-CoV-2, of the total amount of antibody (total antibody) and of S-IgG were 71.3%, 81.9%, and 92.6%, respectively, among fully vaccinated PLWH. Among all participants, PLWH had lower neutralizing activity, total antibody, S-IgG, and T-cell-specific immune response levels, compared to HIV-negative individuals, after controlling for types of vaccine, time interval between first and second dose, time after receiving the second dose, and sociodemographic factors. PLWH with a longer interval since HIV diagnosis, who received their second dose 15–28 days prior to study commencement, and who had an interval of ≥21 days between first and second dose had higher neutralizing activity levels. The immunogenicity of the inactivated SARS-CoV-2 vaccines was lower among PLWH as compared to HIV-negative individuals. Vaccination guideline specific for PLWH should be developed. |
format | Online Article Text |
id | pubmed-8875274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88752742022-02-26 Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China Huang, Xiaojie Yan, Ying Su, Bin Xiao, Dong Yu, Maohe Jin, Xia Duan, Junyi Zhang, Xiangjun Zheng, Shimin Fang, Yuan Zhang, Tong Tang, Weiming Wang, Lunan Wang, Zixin Xu, Junjie Viruses Article This study compared the immunogenicity of inactivated SARS-CoV-2 vaccines between people living with HIV (PLWH) and HIV-negative individuals. We recruited 120 PLWH and 53 HIV-negative individuals aged 18–59 years who had received an inactivated SARS-CoV-2 vaccine in two Chinese cities between April and June 2021. Blood samples were tested for immunogenicity of the inactivated SARS-CoV-2 vaccines. The prevalence and severity of adverse events associated with SARS-CoV-2 vaccines were similar between PLWH and HIV-negative individuals. The seropositivity of neutralizing activity against authentic SARS-CoV-2, of the total amount of antibody (total antibody) and of S-IgG were 71.3%, 81.9%, and 92.6%, respectively, among fully vaccinated PLWH. Among all participants, PLWH had lower neutralizing activity, total antibody, S-IgG, and T-cell-specific immune response levels, compared to HIV-negative individuals, after controlling for types of vaccine, time interval between first and second dose, time after receiving the second dose, and sociodemographic factors. PLWH with a longer interval since HIV diagnosis, who received their second dose 15–28 days prior to study commencement, and who had an interval of ≥21 days between first and second dose had higher neutralizing activity levels. The immunogenicity of the inactivated SARS-CoV-2 vaccines was lower among PLWH as compared to HIV-negative individuals. Vaccination guideline specific for PLWH should be developed. MDPI 2022-01-28 /pmc/articles/PMC8875274/ /pubmed/35215870 http://dx.doi.org/10.3390/v14020277 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Huang, Xiaojie Yan, Ying Su, Bin Xiao, Dong Yu, Maohe Jin, Xia Duan, Junyi Zhang, Xiangjun Zheng, Shimin Fang, Yuan Zhang, Tong Tang, Weiming Wang, Lunan Wang, Zixin Xu, Junjie Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China |
title | Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China |
title_full | Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China |
title_fullStr | Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China |
title_full_unstemmed | Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China |
title_short | Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China |
title_sort | comparing immune responses to inactivated vaccines against sars-cov-2 between people living with hiv and hiv-negative individuals: a cross-sectional study in china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875274/ https://www.ncbi.nlm.nih.gov/pubmed/35215870 http://dx.doi.org/10.3390/v14020277 |
work_keys_str_mv | AT huangxiaojie comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT yanying comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT subin comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT xiaodong comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT yumaohe comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT jinxia comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT duanjunyi comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT zhangxiangjun comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT zhengshimin comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT fangyuan comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT zhangtong comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT tangweiming comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT wanglunan comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT wangzixin comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina AT xujunjie comparingimmuneresponsestoinactivatedvaccinesagainstsarscov2betweenpeoplelivingwithhivandhivnegativeindividualsacrosssectionalstudyinchina |